LTC Webinar with Christian Angermayer

18 November 2020

We were excited to host a webinar with Christian Angermayer – serial entrepreneur and investor passionate about mental health issues. With his biotech company ATAI Life Sciences, Christian has the ambitious goal to find cures for mental health issues by bringing back formerly vilified drugs like psychedelics into the legal realm.

Christian is founder of Apeiron Investment Group and Elevat3 Capital – which focuses on technology in the areas of artificial intelligence, space technology, internet security, biotech, blockchain and fintech in Germany and other countries in Europe.

He laid the foundations for his success with Ribopharma in 2000, which merged with US peer Alnylam in 2003 and subsequently went public. Since then, Christian has created, co-founded and invested in numerous successful companies, has raised approx. USD 2 billion for his portfolio companies and has been involved in more than 40 successful IPO- and M&A-transactions.

An avid reader, Christian made some interesting book recommendations to our viewers – please see below.

1. How to Change Your Mind: The New Science of Psychedelics

Michael Pollan

2. Stealing Fire: How Silicon Valley, the Navy SEALs, and Maverick Scientists Are Revolutionizing the

Way We Live and Work

Steven Kotler

3. Think and Grow Rich

Napoleon Hill

4. Immortality Key, The: The Secret History of the Religion with No Name

Brian Muraresku, C.

Please also subscribe to our newsletter to receive information about our future activities.

The value of your investment may go down as well as up and, therefore, your capital is at risk. Investments in venture capital funds and projects are particularly risky and you may lose all your invested capital so you will need to ensure that you are able to afford this loss. Investments should only be made by investors who understand the risks. London Technology Limited (FRN: 821696) is an appointed representative of Red Sky Capital Solutions LLP (FRN: 530676) which is authorised and regulated by the UK Financial Conduct Authority.